PrepTest 151
[lcid:3701] Prep Test 151 LSAT — Logical Reasoning — S2
Logical reasoning
Question prompt
Last year, pharmaceutical manufacturers
Remaining source text redacted.
Why the credited answer is right
Credited answer: A
The notes below walk through why it fits the stem and how to eliminate the rest.
Question Type
Weaken Questions
Answer choices
-
AMost pharmaceutical manufacturers increased Remaining source text redacted.
Why choice A matches the stem
Correct. Argument or Facts:
Argument
Valid or Flawed:
Flawed
Question Type:
Weaken
Stimulus Summary:
Big Pharma spends promotional money primarily through doctor visits. Last year, they upped their budget. However, the average number of visits per representative decreased substantially. Therefore, it must not have worked and physicians were less likely to take a meeting with a sales rep.
Answer Anticipation:
The author here jumps between a stat (fewer visits) to an explanation (doctors less willing to have visits). Whenever an author posits an explanation, it's important to think about alternative explanations.
Here, could there be another explanation for the lower number of visits, one that allows for the visits to still be productive? Sure. Maybe the sales reps were able to stay longer at each visit, thus preventing the need for a follow-up. After all, we're told the number of visits per representative went down. If there were more reps, there could have been the same number of visits overall.
Answer Explanation:
Right off the bat, we're given an alternative. The author believes the lower number of visits shows the increase in spending was counterproductive, but this answer raises the possibility that the lower number of visits per rep was a factor of having more representatives spending more time with the doctors, which could very well have increased profits.
Key Takeaway:
When an explanation is presented as the conclusion in a Weaken question, the correct answer will frequently present an alternative explanation. -
BPhysicians who receive visits Remaining source text redacted.
Why choice B is not credited
Incorrect. The stimulus never states that fewer physicians received visits from the representatives. Picking this answer reflects a jump the author of the question tried to get you to make—mainly, thinking that fewer visits per rep would necessarily lead to fewer doctors visited. But, as stated before, if the companies spent that budget on more representatives, coverage could have stayed the same. -
CMost pharmaceutical companies did Remaining source text redacted.
Why choice C is not credited
Incorrect. This answer rules out another method by which Big Pharma could have spent money to drive up sales. In an argument that was trying to find the cause of an increase in sales, this would serve as a strengthener. In an argument about whether one particular method was effective, information about a different method is out of scope. -
DMost physicians who agree Remaining source text redacted.
Why choice D is not credited
Incorrect. This answer is trying to lead you down a math path, working to figure out how averages and multiple visits would work. Don't do it. This answer presents a fact that would be true in both years in question, so it's unclear how it could weaken an explanation for how effective a certain change was. -
EThe more visits a Remaining source text redacted.
Why choice E is not credited
Incorrect. First, this answer relies on you making the false assumption that fewer visits per representative means fewer visits per doctor, which we've already discussed as fallacious. Second, even if we ignore that for a second, this answer aligns with the author's determination that the plan was ineffective.
What this tests
Discussion
-
Started by HaydenB
-
Started by kellycrabtree
-
Help 1 reply
Started by beraiahgenesis